Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Lantheus
LNTH
5
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
MNOV MediciNova
- 1.540
- -0.050-3.14%
Trading Apr 30 11:08 ET
75.53MMarket Cap-6.70P/E (TTM)
1.540High1.460Low9.20KVolume1.600Open1.590Pre Close13.98KTurnover0.02%Turnover RatioLossP/E (Static)49.05MShares2.55052wk High1.44P/B64.80MFloat Cap1.12052wk Low--Dividend TTM42.08MShs Float16.120Historical High--Div YieldTTM5.03%Amplitude1.120Historical Low1.518Avg Price1Lot Size
About MediciNova Company
MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
Company Profile
SymbolMNOV
Company NameMediciNova
Listing DateDec 7, 2006
Founded2000
CEODr. Yuichi Iwaki,M.D.,PhD
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address4275 Executive Square,Suite 300
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-373-1500
Websitehttp://www.medicinova.com
Company Executives
- Name
- Position
- Salary
- Dr. Yuichi Iwaki,M.D.,PhD
- Chairman of the Board, President and Chief Executive Officer
- 1.39M
- David H. Crean, PhD
- Chief Business Officer
- --
- Jason J. Kruger
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Kazuko Matsuda
- Director and Chief Medical Officer
- 1.01M
- Nicole Lemerond
- Independent Director
- 46.16K
- Carolyn D. Beaver, C.P.A.
- Independent Director
- 69.23K
- Hideki Nagao
- Independent Director
- 69.23K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call